242
Participants
Start Date
January 6, 2020
Primary Completion Date
May 20, 2021
Study Completion Date
May 20, 2021
CKD-495 75mg
CKD-495 75mg Tab.
Artemisia Herb 95% Ethanol Soft Ext.(20→1) 60mg
Artemisiae argyi folium 95% ethanol ext.(20→1) 60mg Tab.
Placebo of the CKD-495 75mg
Placebo of the CKD-495 75mg Tab.
Placebo of Artemisia Herb 95% Ethanol Soft Ext.(20→1) 60mg
Placebo of Artemisia Herb 95% Ethanol Soft Ext.(20→1) 60mg Tab.
Chonnam National University Hospital, Gwangju
Kyoungpook National University Hospital, Daegu
Busan National University Hospital, Busan
Inje University Busan Paik Hospital, Busan
Yeungnam University Medical Center, Daegu
Chonbuk National University Hospital, Jeonju
Seoul National University Bundang Hospital, Seongnam
Chung Ang University Hospital, Seoul
Hanyang University Medical Center, Seoul
Kangbuk Samsung Hospital, Seoul
Korea University Anam Hospital, Seoul
Korea University Guro Hospital, Seoul
Samsung Medical Center, Seoul
Seoul National University Hospital, Seoul
Severance Hospital, Seoul
The Catholic University of Korea, Seoul ST. Mary's Hospital, Seoul
Yeouido ST. Mary's Hospital, Seoul
Lead Sponsor
Chong Kun Dang Pharmaceutical
INDUSTRY